Estimation of the prevalence of depression from the daily defined doses of antidepressive drugs
Llop, C.; Ribas, J.; Rovira, E.
Medicina Clinica 110(14): 557-558
1998
ISSN/ISBN: 0025-7753 PMID: 9646274 Document Number: 494345
Document emailed within 1 workday
Related Documents
Beresewicz, M.; Bidzińska, E.; Koszewska, I.; Puzyński, S. 1991: Results of using tricyclic antidepressive drugs in the treatment of endogenous depression (comparative analysis of 7 drugs) Psychiatria Polska 25(3-4): 13-18Náhunek, K.; Svestka, J.; Rodová, A. 1971: To the antidepressive properties of lithium and its place in the group of antidepressive drugs Activitas Nervosa Superior 13(3): 169-170
Khachanov, R.M. 1971: The dynamics of partial renal function in renal tuberculosis during treatment with single daily doses of antitubercular drugs Problemy Tuberkuleza 49(2): 42-45
Martínez-Suárez, M.M.; Blázquez-Menes, B. 2000: Estimation of the prevalence of Parkinson's disease in Asturia, Spain. a pharmacoepidemiological study of the consumption of antiparkinson drugs Revista de Neurologia 31(11): 1001-1006
Knud Larsen, J. 2012: Mirtazapine versus other antidepressive agents for depression Ugeskrift for Laeger 174(46): 2864-2866
Bilikiewicz, A.; Januszkiewicz-Grabiasowa, A.; Deptulski, T.; Taraszkiewicz, W.; Wojtowicz, M. 1977: Changes in the ECG in the course of treatment of endogenous depression with tricyclic antidepressive agents Psychiatria Polska 11(5): 511-517
Ivancová, J.; Stika, L.; Pecka, V. 1980: Drug consumption in defined daily dose per day of treatment --follow-up technique Casopis Lekaru Ceskych 119(33-34): 885-889
Adler, M.; Göran, I. 2010: Conclusions on the efficiency of antidepressive agents in mild to moderate depression should wait Lakartidningen 107(18): 1248
Kupryś-Lipińska, I.; Tworek, D.; Vanderbist, F.; Bocheńska-Marciniak, M.łg.; Kuna, P. 2013: Efficacy and safety of a 12-week therapy with a new formulation of fluticasone propionate at doses of 125 and 250 μg administered through a new generation cyclohaler twice daily, in comparison to fluticasone propionate 500 μg dry powder inhaler twice daily in patients with moderate asthma Pneumonologia i Alergologia Polska 81(6): 527-536
Wehrlin, N. 1973: Antidepressive drugs or thymoanaleptics Revue de l'Infirmiere 23(9): 887-892
Kim, M.H.; Mazenga, A.C.; Devandra, A.; Ahmed, S.; Kazembe, P.N.; Yu, X.; Nguyen, C.; Sharp, C. 2014: Prevalence of depression and validation of the Beck Depression Inventory-Ii and the Children's Depression Inventory-Short amongst HIV-positive adolescents in Malawi Journal of the International Aids Society 17: 18965
Zavrsnik, D.; Spirtović, S.; Becić, F. 2006: Antidepressives and antidepressive interactions with other drugs Medicinski Arhiv 60(1): 63-67
Stazi, C.; Stazi, F. 1991: The cardiovascular system and antidepressive drugs La Clinica Terapeutica 137(2): 125-135
Fossati, C.; Giustiniani, S. 1985: Cardiotoxicity caused by the use of antidepressive drugs La Clinica Terapeutica 115(6): 491-495
Bernardo, M. 1997: Antidepressive drugs: yesterday, today and tomorrow? Medicina Clinica 108(5): 180-181
Kunz, R.; Leuthold, A.; Buddeberg, C. 1998: Sexual dysfunctions with antidepressive drugs--results of a physician survey Praxis 87(18): 610-616
Engler, E.; Matthias, D.; Herrmann, H.J.; Becker, C.H. 1976: Studies on the blood pressure effects of various high doses of angiotensin II in depot form in rats under defined conditions Acta Biologica et Medica Germanica 35(7): 983-994
Puech, A. 1994: The significance of evaluating animal behavior with psychotropic drugs and especially with antidepressive agents L'Encephale 20(Special Issue 2): 247-249
Desgrées du Loû, A.; Msellati, P.; La Ruche, G.; Welffens-Ekra, C.; Ramon, R.; Dabis, F. 1999: Estimation of HIV-1 prevalence in the population of Abidjan by adjustment of the prevalence observed in antenatal centres Aids 13(4): 526-527
Milhaud, G.; Pitovic, R. 1992: Calcitonin an XXVI. Value of replacement doses in daily practice Therapie 47(1): 29-34